HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein.

AbstractBACKGROUND/AIMS:
Hepatocellular carcinoma frequently invades the portal veins, and when it invades the main portal vein, the patient's prognosis is extremely poor. This study was undertaken to evaluate the clinical efficacy of stent placement into the portal vein in these patients.
METHODS:
Twenty-one patients with hepatocellular carcinoma invading the main portal vein were studied. Stents were placed in the portal veins to compress tumor thrombi after percutaneous transhepatic portography.
RESULTS:
Stents were successfully placed in the portal veins in all patients. Portal venous pressure significantly decreased from 25.3 +/- 7.4 mmHg to 22.4 +/- 6.6 mmHg (p < 0.0001) immediately after stent placement, leading to improvement in gastroesophageal varices, melena and ascites. Although a pseudoaneurysm of the hepatic artery related to portal vein puncture developed in one patient, there were no major complications in the other 20 patients. Blood flow through the stent was maintained during the survival period in 15 patients. The mean stent patency period was 12.4 months. Fifteen patients underwent transcatheter arterial chemoembolization without major complications after stent placement. The survival rate was 64.2% at 6 months and 29.2% at 1 and 2 years, respectively. The mean survival period was 13.7 months.
CONCLUSION:
Stent placement into the portal vein is a relatively safe and feasible procedure. It improves portal hypertension, expands treatment options, and helps to prolong the survival period in patients with hepatocellular carcinoma invading the main portal vein.
AuthorsK Yamakado, N Tanaka, A Nakatsuka, K Matsumura, K Takase, K Takeda
JournalJournal of hepatology (J Hepatol) Vol. 30 Issue 4 Pg. 660-8 (Apr 1999) ISSN: 0168-8278 [Print] Netherlands
PMID10207808 (Publication Type: Journal Article)
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Ascites
  • Carcinoma, Hepatocellular (complications, mortality, pathology)
  • Chemoembolization, Therapeutic
  • Esophageal and Gastric Varices (therapy)
  • Female
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms (complications, mortality, pathology)
  • Male
  • Melena
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Portal Vein (pathology, surgery)
  • Stents (adverse effects)
  • Survival Rate
  • Time Factors
  • Venous Thrombosis (etiology, mortality, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: